Iclusig (Ponatinib) 15mg

Iclusig 15mg is a prescription medication used for certain types of leukemia. It belongs to the tyrosine kinase inhibitor class and is designed to target specific cancer cells. This oral tablet helps manage chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Strength

15mg

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Iclusig 15mg is prescribed for patients with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is typically used when other treatments have not been effective or when specific genetic mutations are present. The medication works by blocking signals that promote cancer cell growth. It may also be used in other cases as determined by a healthcare professional.

Side Effects

Iclusig 15mg helps reduce the progression of certain blood cancers by targeting abnormal proteins in cancer cells. Patients may experience improved blood cell counts and reduced symptoms over time. Common effects include fatigue, skin rash, or digestive discomfort. Individual responses vary, and regular monitoring is advised.

Precautions & Warnings

Iclusig 15mg should be taken exactly as prescribed by a healthcare provider. Patients should inform their doctor about all medications, supplements, and medical conditions before starting treatment. Blood tests are typically required to monitor response and side effects. Avoid grapefruit products unless approved by a doctor.

Avoid Interactions

Iclusig 15mg may interact with other medications, including strong CYP3A inhibitors or inducers, which can affect its effectiveness. Alcohol and certain herbal supplements may also interact. Patients should discuss all current medications with their healthcare provider to minimize risks. Regular monitoring helps manage potential interactions.

Frequently Asked Questions

Iclusig 15mg is used to treat certain types of leukemia, including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Iclusig 15mg should be taken exactly as prescribed by a healthcare provider, usually once daily with or without food.

Common side effects may include fatigue, skin rash, or digestive discomfort. Patients should report any persistent issues to their doctor.

Grapefruit products may interact with Iclusig 15mg; consult your healthcare provider before consuming them.

Iclusig 15mg is a targeted therapy, not a traditional chemotherapy drug, as it works by blocking specific signals in cancer cells.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.